Follow The Filings

JCI Johnson Controls

Industrials, filed as JOHNSON CTLS INTL PLC (SHS), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2, sold by 3

  • 1 Owner
  • #112
  • Max 0.1%
  • Master 0.59%
  • $237K

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. 0.12%

Who owns JCI

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.12% Hold 1,594 $237K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by JCI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All JCI insider trades
  • $1M bought by 1 insider
  • $26.9M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Juergen Tinggren Director
    Sale
    $637K 4,000 shares at $159.19 13% of stake
    Traded Oct 28 Filed Oct 29
    ↗
  2. Pierre E Cohade Director
    Sale
    $488K 3,300 shares at $147.79 23% of stake
    Traded Aug 19 Filed Aug 19
    ↗
  3. Lei Zhang Schlitz VP & Pres, GP & Solutions
    Sale
    $3.6M 23,417 shares at $153.07 61% of stake
    Traded Aug 4 Filed Aug 5
    ↗
  4. Todd M Grabowski VP and President, Americas
    Sale
    $263K 1,800 shares at $146.20 6.4% of stake
    Traded Jun 9 Filed Jun 9
    ↗
  5. Todd M Grabowski VP and President, Americas
    Sale
    $622K 4,274 shares at $145.50 13% of stake
    Traded May 14 Filed May 18
    ↗
  6. Lei Zhang Schlitz VP & Pres, GP & Solutions
    Sale
    $12.5M 88,809 shares at $140.99 61% of stake
    Traded May 8 Filed May 12
    ↗
  7. Daniel C McConeghy VP Chief Accounting & Tax Ofcr
    Sale
    $513K 3,600 shares at $142.56 13% of stake
    Traded Feb 23 Filed Feb 23
    ↗
  8. Todd M Grabowski VP and President, Americas
    Sale
    $816K 6,050 shares at $134.90 15% of stake
    Traded Feb 6 Filed Feb 10
    ↗
  9. Mark Vergnano Director
    Buy
    $1M 7,665 shares at $131.94 +26% to stake
    Traded Feb 5 Filed Feb 5
    ↗
  10. John Donofrio Exec VP & General Counsel
    Sale
    $2.5M 21,595 shares at $116.00 53% of stake
    Traded Dec 10, 2025 Filed Dec 11, 2025
    ↗
  11. Lei Zhang Schlitz VP & Pres, Global Products
    Sale
    $3.6M 32,031 shares at $113.20 32% of stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
    ↗
  12. Lei Zhang Schlitz VP & Pres, Global Products
    Sale
    $1.3M 10,500 shares at $122.03 8.4% of stake
    Traded Nov 6, 2025 Filed Nov 7, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 51 share withholdings for taxes, 31 stock grants, 5 gifts, 3 sales back to the company, and 2 option exercises.

Congress

3 members of Congress traded JCI in the last three years: 3 buys and 4 sales. 9 members listed it in 2025 annual reports.

All Congress trades
  1. Julia Letlow R-LA-5 Sell $1K–$15K Oct 2, 2025 filed Jan 13
  2. Julia Letlow R-LA-5 Partial sale $1K–$15K Jul 25, 2025 filed Jan 13
  3. Julia Letlow R-LA-5 Buy $1K–$15K Mar 19, 2025 filed Jan 13
  4. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Aug 19, 2025 filed Sep 12, 2025
  5. Val T. Hoyle D-OR-4Spouse Buy $1K–$15K Oct 29, 2024 filed Sep 12, 2025
  6. Bruce Westerman R-AR-4 Sell $1K–$15K Apr 21, 2025 filed May 12, 2025

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
8-K/A 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated about 16 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $26.79B $22.95B $23.6B
Gross profit $8.97B $8.08B $8.59B
Gross margin * 33.5% 35.2% 36.4%
Net income $1.85B $1.7B $3.29B
Net margin * 6.9% 7.4% 13.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $10.74B $11.18B $10.16B
Total non-current assets * $31.5B $31.52B $27.78B
Total assets $42.24B $42.7B $37.94B
Total current liabilities $11.08B $11.96B $10.94B
Total non-current liabilities $13.46B $13.38B $14.04B
Total equity $16.54B $16.1B $12.93B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from investing -$1.18B — —
Cash from financing -$2.17B — —
Net change in cash -$1.14B -$0.15B -$0.369B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.